Introduction
Androgens are traditionally considered as the male sex hormones whereas estrogens as the female sex hormones. However in both sexes, the androgens are metabolized to estrogens and there is an increasing evidence indicating that both types of hormones play an important role for regulation of physiological functions in both sexes. It has, however, been suggested that an excessive exposure to estrogens may be deleterious to normal male reproductive function [1] . This may be in particular true if the exposure takes place in early fetal life at the time of sexual differentiation [2] . It also has become evident that a number of environmental toxicants may mimic the effect of estrogens and thereby disturb the male fertility. Such effect may also be exerted by the so-called phytoestrogens, a group of substances that are derived from plants and have biological effects on animals similar to those of estrogen.
Much of the current research focusing on the impact of estrogens and phytoestrogens on male fertility has been a consequence of epidemiological data pointing to possible time-related and geographical trends in male reproductive function.
In this review, these data are described and subsequently some of the recent research in relation to estrogens/ phytoestrogens and male fertility is summarized.
Male reproductive function -epidemiologic trends
In 1992, a meta-analysis by Carlsen et al.
[3] indicated a decline in mean sperm count from 113 million/ml in 1940 to 66 million/ml in 1990. These results are still an object of discussion and statistical reanalyses performed on the same material have led to somewhat diverging conclusions. One confirmed a statistically significant decline both in the USA and in Europe, whereas others stated that the decline was not present at all [4] [5] [6] . Recently, in a study of semen quality in military conscripts in Southern Sweden, no significant difference in sperm number or motility was seen between 2000-2001 and 2009-2010 [7 ] . Furthermore, in Denmark, where monitoring of sperm counts in adolescent men has taken place during the past 15 years, no negative trend in sperm numbers has been observed [8] . In contrary, in a Finish study of army conscripts during the same period, such decrease was reported [9] . These are the first prospective data regarding secular trends in semen quality. However, these findings do not exclude that in some parts of the world a decline had already happened but was leveled off after 2000.
The other interesting point is whether the male fertility potential has decreased during the past years. A recent Swedish study has shown a time-related decrease in the proportion of couples with more than 1 year's time to pregnancy [10] . However, this finding might reflect a country-specific decrease over time in sexually transmitted diseases, changes in sexual behaviour induced by socioeconomic conditions, or educational trends, rather than being a result of improvement in testicular and/or ovarian function.
The possible decrease in sperm number has been linked to possible deterioration in other indices of male reproductive function. Although a significant 2-4 times increase in the incidence of testicular cancer during the past 50 years has been observed globally, at least among Caucasians, the data indicating the same trend for the risk of hypospadias and cryptorchidism are less reliable [11] [12] [13] [14] [15] .
Furthermore, apart from the time-related trend some interesting geographical differences in regard to the male reproductive function have been observed.
Cancer register data show that the incidence of testicular cancer is five times higher among Danish as compared with Finnish men [11] . Studies on semen quality performed in the 1990s have revealed significantly higher sperm counts in Finland as compared with Denmark. However, according to the most recent data, the Finnish sperm counts have decreased to the Danish level [9] . Furthermore, despite the differences in sperm numbers found between the fertile men from these two countries, no discrepancy with regard to time-to-pregnancy has been observed [16] , indicating that fertility may be a less sensitive marker of male reproductive dysfunction.
Regional differences in sperm numbers also have been found in the USA and across Europe [17, 18] .
The explanation for this geographical trend is not known. The reports showing that the incidence of testicular cancer in the second generation immigrants in Sweden and Denmark, who have the risk of this malignancy at the magnitude of males in the country in which they are living and not at that of the background population from which their parents are pointing to a strong effect of environment and/or lifestyle [19, 20] .
Testicular dysgenesis syndrome
The above-mentioned studies not only showed common epidemiological trends for congenital abnormalities of male genital organs as well as semen quality and risk of testicular cancer, but also indicated that testicular germ cell cancer (TGCC) and low sperm counts may share causes and be the result of factors operating already in fetal life. On the basis of these observations as well as clinical evidence linking cryptorchidism, hypospadias, poor semen quality, and testicular malignancy together, Skakkebaek et al. [21] in 2001 coined the concept of testicular dysgenesis syndrome (TDS), suggesting that poor semen quality, testis cancer, cryptorchidism, and hypospadias are symptoms of a common underlying entity (Fig. 1) . TDS was suggested to be a result of disruption of embryonal programming and gonadal development in fetal life due to environmental or lifestyle related factors combined with genetic susceptibility of the individual.
Originally, it was hypothesized that the fetal disturbances in the development of the male reproductive system is related to an increased exposure to endogenous or exogenous compounds with estrogenic properties [1]: However, subsequently, the concept of 'estrogen hypothesis' was changed to an imbalance between the androgenic and estrogenic action in favor of the latter [22] . Interestingly, a recent review of the available human data concluded that 'with the possible exception of testicular cancer there is no strong epidemiological evidence to indicate that prenatal exposure to estrogen are linked to 520 Andrology, sexual dysfunction and infertility
Key points
Epidemiological data show a time-related increase in the incidence of testicular cancer and it also has been suggested that even sperm counts have been declining, but the evidence for such a trend is not strong. It has been suggested that fetal exposure to chemicals interfering with sex hormone actionendocrine disruptors -may lead to impairment of male reproductive function. Some association between adult levels of exposure to endocrine disruptors and semen quality parameters has been reported but the results are not unequivocal and the human data on fetal exposure are lacking. There are no convincing data showing that phytoestrogens in humans may be deleterious to male fertility/semen quality.
disturbed development of the male reproductive organs' [23] .
Sex hormones in male and cellular mechanisms of action
Testosterone is transported to target tissues in a protein bound state, mainly bound to albumin (50-55%) or to sex hormone binding globulin (40-45%). Normally, the fraction of free testosterone is only 2% in the circulation of men. It dissociates from carrier proteins and enters the cell via passive diffusion. In the cytoplasm, testosterone can be converted to the more potent androgen dihydrotestosterone (DHT) by the enzyme 5a-reductase as well as to estradiol by the enzyme aromatase. Both testosterone and DHT exert their actions through the intracellular androgen receptor (AR). Failure of the AR to activate its target genes in the presence of hormone results in target organ resistance to the hormone, phenotypically ranging from complete feminization to mild under-virilization in males [24] .
Estrogens are exerting their action through two types of estrogen receptor (ER): ERa and ERb. Both receptors are expressed in the human testis. ERa mostly found in the rete testis whereas ERb has been found in both Sertoli cells and the germ cells. More recently, it has become clear that estradiol actions can also rapidly be mediated through a membrane associated or intracellular estrogen receptor [25] . Recent investigations show that the cellular activities of estrogens and xenoestrogensproducts of industrial or chemical processing that have estrogen-like effects -are the result of a combination of both pathways [26] .
The impact of estrogens on spermatogenesis is only poorly understood. Thus, administration of estrogens to prostate cancer patients and to male to female transsexuals, results in atrophy of the seminiferous tubules [27, 28] . However this effect might be indirect, mediated through a negative feedback on the secretion of gonadotropins. Disturbances in spermatogenesis were also observed in aromatase knockout mice [29] , this finding indicating a functional role of these hormones in relation to normal sperm production. Thus, in principle, both an excess and a lack of estrogenic action may be deleterious for spermatogenesis.
Endocrine disrupters -molecular actions
The endocrine system can be considered as a closed feedback loop that functions to maintain homeostasis. Many of the industrially produced chemicals were shown in vitro and in animal studies to act like hormones in the endocrine system and to disrupt the physiologic function of endogenous hormones, so-called endocrine disrupting compounds (EDCs) [2] .
Many EDCs identified do in fact interfere with estrogenic actions (see below), modifying the synthesis or actions of estradiol or interfering with the estrogen receptors. These chemicals include drugs, natural products, and manufactured chemicals.
Although animal studies have raised concern that the influence of EDCs would obstruct the development of the male reproductive system, in general, exposure levels far above those found in humans have been needed to evoke reproductive toxicity in the animal models. Human data are inconclusive and have evoked the question of whether EDCs can have any impact on hormonal function and thus health consequences when natural hormones are present. Indeed, many contaminants with hormone-like activity are much less potent than
endogenous hormones themselves [30] ; 17b-estradiol was for instance estimated to be 17 000 times more potent than p,p'-dichlorodiphenyltrichloroethane. However, humans are exposed to a multitude of agents, and when present in sufficient number and/or concentration, they might in principle act together to impact on the actions of endogenous hormones. Whether such impacts will be physiologically relevant is still not known, but in a worst case scenario, there are no threshold levels below which there are no effects at all.
A number of environmentally derived chemicals were shown to have an estrogenic effect or to interfere with the synthesis or metabolism of this hormone. Some of those are listed in Table 1 (http://en.wikipedia.org/wiki/ Xenoestrogen).
During the recent period, a lot of research has been focusing on finding possible associations between levels of certain EDC and semen quality. Originally most of those studies focused on persistent organohalogen pollutants as polychlorinated biphenyl (PCB) and p,p'-dichlorodiphenyldichloroethylene [31] . During the most recent years, in particular phthalates [32, 33] and Bisphenol A [34, 35 ] have been on the research agenda. Some of the most recent of these studies are summarized in Table 2 . In general, those reports point to some negative association between the exposure levels and sperm number/quality. However, it should be kept in mind that these studies have been focusing on exposure during the adult life, there being no data on fetal exposure which according to the TDS hypothesis (see above) should be the most deleterious to the male reproductive function. Furthermore, some publication bias in favor of studies concluding association between levels of EDC and semen quality/fertility cannot be excluded.
Apart from chemicals interfering directly with estrogenic action, synthesis and/or metabolism, it can be speculated that those affecting the AR or aryl hydrocarbon receptoras 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) -may indirectly have an impact on the activity of the estrogen receptor. Interestingly, deterioration in semen quality has recently been reported in sons to mothers exposed to dioxin after the accident in Seveso [39 ] (Fig. 2) .
Phytoestrogens
Phytooestrogens are nonsteroidal compounds that can bind to both ERa and ERb because of their ability to mimic the conformational structure of estradiol [41] . Phytooestrogens are found in many vegetables and are particularly abundant in soy products. Genistin and daidzin, two major soy isoflavone glucosides, are present at high concentrations in soybeans and soybean-derived products and are a major source of xeno-oestrogen exposure in both humans (e.g., soy-based formula for infants; tofu) and animals (most commercially available diets). Many foods such as walnuts, soybeans, cereals (oats, barley, wheat, rice), legumes (beans, lentils), berries, apples, carrots, ginseng, fennel, and anise used to barboun and beer contain phytoestrogens. The oils of seeds, soya beans and tofu are foods that contain the highest concentration of phytoestrogens.
The mechanism of action of phytoestrogens in relation to male reproductive function is not only limited to their interaction with estrogen receptors. Genistein also has 522 Andrology, sexual dysfunction and infertility been reported to act through other mechanisms, including acting as a tyrosine kinase inhibitor or an antioxidant [42, 43] . Furthermore, it has been suggested [44 ] that phytooestrogen exposure might interfere with the androgen receptor pathway and affect the late steps of spermatogenesis.
Generally, soy isoflavones have received much attention as a result of their potential health benefits. Soy consumption in oriental countries correlates with low incidences of breast and invasive prostate cancers, improvements in metabolic parameters, and amelioration of age-related diseases, for example, cardiovascular diseases, osteoporosis [45, 46] . However, exposure to high levels of phytoestrogens, either from a lifetime of exposure or during a critical period of development, also could have potentially detrimental effects on fertility and reproductive functions, through the molecular mechanisms described above.
However, so far, there has been a lack of consistency in human and animal studies examining the effects of soy and phytooestrogens on reproductive parameters (Table 3) .
These discrepancies certainly reflect inadequate descriptions or insufficient sample size to permit confidence in the observed results and also the variety of experimental designs, in some cases the exposure levels applied in animal studies being at significantly higher level than the dose expected to be found in humans.
Semen data from Asia, where the consumption of phytoestrogens is more pronounced than in other parts of the world, are rather scarce. However, a recent review [51] might indicate that sperm numbers, in this part of the world, are about the same level as the lowest ones seen in Europe. Whether this is due to the diet, other lifestyle related factors and/or genetic diversity cannot be concluded.
Another intriguing issue is the timing of the exposure an important question being whether exposure during infancy causes detrimental male reproductive effects in adulthood. A study that has assessed the adult reproductive effects of soy formula consumption during infancy in humans reports that no significant differences in onset of puberty or in reproductive functions were found in comparison with those fed with milk formulas [52] . However, the true relevance of this study has been the subject of controversy, as a result of the lack of direct measurements of hormone levels and reproductive functions [53, 54] .
Other important aspects to be taken into consideration are the impact of mixed exposure. An intriguing question is whether a mixture of different EDCs, a scenario which Estrogens and phytoestrogens in male infertility Giwercman 523 reflects the day-to-day situation, can be deleterious at exposure doses at which no effect of single compound can be measured. Recently, it was reported that the relatively weak alterations in reproductive function of males exposed to low doses of genistein (1 mg/kg/day) were exacerbated when co-exposed with a low dose of the fungicide vinclozolin (1 mg/kg/day), a ubiquitous antiandrogenic food contaminant [55] . Indeed, the genistein/ vinclozolin mixture induced greater alterations on the male reproductive tract and fertility endpoints when compared with the exposure to each compound in isolation, at the same dose.
Gene-environment interaction
During the past few years an increasing amount of epidemiological and in-vitro data have indicated possible gene-environment interaction in relation to the effect of EDC on the male reproductive system. Thus, we have previously reported that the negative effect of PCB exposure in relation to the sperm numbers may only be seen in males with a certain variant of the androgen receptor gene [56] . This might also be true in relation to polymorphisms in the ERa and ERb as well as genes involved in the synthesis or metabolism of estrogens as well as those encoding for receptors interfering with the action of estrogen receptor as, for example, aryl hydrocarbon receptor. Thus, recently a negative association between obesity and sperm counts was only found in patients with the genetic variants of the aromatase gene resulting in higher estrogen levels [57] .
Gene-environment interaction might also encounter for regional differences in sperm numbers.
Conclusion
Phytoestrogens as well environmental chemicals, directly or indirectly interfering with the physiological effect of estrogens, might in principle interfere with the function of the male reproductive system. However, convincing human evidence that such exposures, at levels to which general population is exposed has an impact on male fertility, is still lacking. On the contrary, due to a serious potential consequence of such a scenario, intensive research is needed in order to elucidate whether there is any reason to worry or not. Thus, the future research agenda should focus on studies related to fetal exposure, the impact of mixed exposure of low doses of different chemicals, and gene-environment interaction. For the clinician, this issue is interesting but yet, without any clear clinical implications. Although aromatase inhibitors have been tested in the treatment of male infertility, evidence for their effects are still lacking.
524 Andrology, sexual dysfunction and infertility Table 3 Human studies evaluating the effects of gestational and postnatal exposure to isoflavones on fertility and male hormones Ethnic group For control groups, the number of individuals (n) is shown in parentheses. D, daidzein; FSH, follicle stimulating hormone; G, gensitein; ND, not determined; T, testosterone. Adapted with permission from [44 ] .
